ACON
Aclarion, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
No implied move.
Next report
Last report
—
Largest filed tie
13F top-10 QoQ
Top fund weight
—
Aclarion, Inc.
Expected move
No implied move.
Next report
Last report
—
Largest filed tie
13F top-10 QoQ
Top fund weight
—
Aclarion, Inc.
1.78
+0.02 · +1.14%
Linked news
−50.50%
shares held · 8 largest managers
No changes.
No changes.
No trades yet today.
No trades yet today.
| Manager | Value | % base | |
|---|---|---|---|
| Bridgeway | $56,102 | 16.89% | new |
| Captrust Financial | $49,130 | 14.79% | +17.17% |
| Vanguard Fiduciary Trustindex-like | $46,161 | 13.90% | new |
| Susquehanna International | $44,222 | 13.31% | new |
| Geodeindex-like | $34,927 | 10.52% | −61.15% |
| Manager | Value | % base | |
|---|---|---|---|
| Bridgeway | $56,102 | 16.89% | new |
| Captrust Financial | $49,130 | 14.79% | +17.17% |
| Vanguard Fiduciary Trustindex-like | $46,161 | 13.90% | new |
| Susquehanna International | $44,222 | 13.31% | new |
| Geodeindex-like | $34,927 | 10.52% | −61.15% |
Same SIC code · 6
Same SEC industry code: Quest Diagnostics Inc, Labcorp Holdings Inc., Veracyte, Inc. and 3 more; no measured co-movers for Aclarion, Inc..
Same SIC code · 6
Same SEC industry code: Quest Diagnostics Inc, Labcorp Holdings Inc., Veracyte, Inc. and 3 more; no measured co-movers for Aclarion, Inc..
Annual filing, covered
10-K parsed · Mar 18 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 18 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.